Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1887)
All Articles published online
|
May 14, 2007 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Liu T, Gou SM, Wang CY, Wu HS, Xiong JX, Zhou F. Pancreas duodenal homeobox-1 expression and significance in pancreatic cancer. World J Gastroenterol 2007; 13(18): 2615-2618 [PMID: 17552012 DOI: 10.3748/wjg.v13.i18.2615] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i18/2615.htm |
| Number | Citing Articles |
| 1 |
Courtney J. Balentine, David H. Berger, Shi‐He Liu, Changyi Chen, John Nemunaitis, F. Charles Brunicardi. Defining the Cancer Master Switch. World Journal of Surgery 2011; 35(8): 1738 doi: 10.1007/s00268-010-0941-2
|
| 2 |
Juan Ma, Bei-Bei Wang, Xiao-Yan Ma, Wei-Ping Deng, Li-Shu Xu, Wei-Hong Sha. Potential involvement of heat shock proteins in pancreatic-duodenal homeobox-1-mediated effects on the genesis of gastric cancer: A 2D gel-based proteomic study. World Journal of Gastroenterology 2018; 24(37): 4263-4271 doi: 10.3748/wjg.v24.i37.4263
|
| 3 |
Shihe Liu, Nikiforos Ballian, Narasimhaswamy S. Belaguli, Sanjeet Patel, Min Li, Nancy Smyth Templeton, Marie-Claude Gingras, Richard Gibbs, William Fisher, F. Charles Brunicardi. PDX-1 Acts as a Potential Molecular Target for Treatment of Human Pancreatic Cancer. Pancreas 2008; 37(2): 210 doi: 10.1097/MPA.0b013e31816a4a33
|
| 4 |
Yasuni Nakanuma, Yasunori Sato. Hilar cholangiocarcinoma is pathologically similar to pancreatic duct adenocarcinoma: suggestions of similar background and development. Journal of Hepato-Biliary-Pancreatic Sciences 2014; 21(7): 441 doi: 10.1002/jhbp.70
|
| 5 |
Deepanshi Dhar, Gagan Deep, Sushil Kumar, Michael F. Wempe, Komal Raina, Chapla Agarwal, Rajesh Agarwal. Bitter melon juice exerts its efficacy against pancreatic cancer via targeting both bulk and cancer stem cells. Molecular Carcinogenesis 2018; 57(9): 1166 doi: 10.1002/mc.22833
|
| 6 |
Saya Igarashi, Takashi Matsubara, Kenichi Harada, Hiroko Ikeda, Yasunori Sato, Motoko Sasaki, Osamu Matsui, Yasuni Nakanuma. Bile duct expression of pancreatic and duodenal homeobox 1 in perihilar cholangiocarcinogenesis. Histopathology 2012; 61(2): 266 doi: 10.1111/j.1365-2559.2012.04218.x
|
| 7 |
Thomas S. Frank, Xiaotian Sun, Yuqing Zhang, Jingxuan Yang, William E. Fisher, Marie-Claude Gingras, Min Li. Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer. Cancer Letters 2015; 363(1): 1 doi: 10.1016/j.canlet.2015.04.009
|
| 8 |
Takahiro Akiyama, Takashi Shida, Hideyuki Yoshitomi, Shigetsugu Takano, Shingo Kagawa, Hiroaki Shimizu, Masayuki Ohtsuka, Atsushi Kato, Katsunori Furukawa, Masaru Miyazaki. Expression of Sex Determining Region Y-Box 2 and Pancreatic and Duodenal Homeobox 1 in Pancreatic Neuroendocrine Tumors. Pancreas 2016; 45(4): 522 doi: 10.1097/MPA.0000000000000504
|
| 9 |
Guisheng Zhou, Jim Sinnett-Smith, Shi-He Liu, Juehua Yu, James Wu, Robbi Sanchez, Stephen J. Pandol, Ravinder Abrol, John Nemunaitis, Enrique Rozengurt, F. Charles Brunicardi. Down-regulation of pancreatic and duodenal homeobox-1 by somatostatin receptor subtype 5: a novel mechanism for inhibition of cellular proliferation and insulin secretion by somatostatin. Frontiers in Physiology 2014; 5 doi: 10.3389/fphys.2014.00226
|
| 10 |
Cristiana Pistol Tanase, Monica Neagu, Radu Albulescu, Eleonora Codorean, Simona Olimpia Dima. Biomarkers in the diagnosis and early detection of pancreatic cancer. Expert Opinion on Medical Diagnostics 2009; 3(5): 533 doi: 10.1517/17530050903117256
|
| 11 |
Thomas Klonisch, Emilia Wiechec, Sabine Hombach-Klonisch, Sudharsana R. Ande, Sebastian Wesselborg, Klaus Schulze-Osthoff, Marek Los. Cancer stem cell markers in common cancers – therapeutic implications. Trends in Molecular Medicine 2008; 14(10): 450 doi: 10.1016/j.molmed.2008.08.003
|
| 12 |
Lukas Perkhofer, Melanie Engler, Johann Gout, Frank Arnold, Mareen Morawe, Markus Breunig, Thomas Seufferlein, Alexander Kleger, Pierre-Olivier Frappart. Pancreatic Ductal Organoids React Kras Dependent to the Removal of Tumor Suppressive Roadblocks. Stem Cells International 2019; 2019: 1 doi: 10.1155/2019/2079742
|
| 13 |
J Wu, S Liu, J Yu, G Zhou, D Rao, C M Jay, P Kumar, R Sanchez, N Templeton, N Senzer, P Maples, J Nemunaitis, F C Brunicardi. Vertically integrated translational studies of PDX1 as a therapeutic target for pancreatic cancer via a novel bifunctional RNAi platform. Cancer Gene Therapy 2014; 21(2): 48 doi: 10.1038/cgt.2013.84
|
| 14 |
J. Ma, M. Chen, J. Wang, H. H.X. Xia, S. Zhu, Y. Liang, Q. Gu, L. Qiao, Y. Dai, B. Zou, Z. Li, Y. Zhang, H. Lan, B. C. Y. Wong. Pancreatic duodenal homeobox-1 (PDX1) functions as a tumor suppressor in gastric cancer. Carcinogenesis 2008; 29(7): 1327 doi: 10.1093/carcin/bgn112
|
| 15 |
Guisheng Zhou, Shi-He Liu, Kelly M. Shahi, Hua Wang, Xueyan Duan, Xia Lin, Xin-Hua Feng, Min Li, William E. Fisher, Francesco J. DeMayo, David Dawson, F. Charles Brunicardi. Negative Regulation of Pancreatic and Duodenal Homeobox-1 by Somatostatin Receptor Subtype 5. Molecular Endocrinology 2012; 26(7): 1225 doi: 10.1210/me.2012-1095
|
| 16 |
Meriem Semache, Julien Ghislain, Bader Zarrouki, Caroline Tremblay, Vincent Poitout. Pancreatic and duodenal homeobox-1 nuclear localization is regulated by glucose in dispersed rat islets but not in insulin-secreting cell lines. Islets 2014; 6(4): e982376 doi: 10.4161/19382014.2014.982376
|
| 17 |
C M Jay, C Ruoff, P Kumar, H Maass, B Spanhel, M Miller, A Arrington, N Montalvo, V Gresham, D D Rao, C Evans, Z Wang, F C Brunicardi, S-H Liu, G Zhou, N Senzer, J Nemunaitis, L King, B Weeks, F J Clubb, T W Fossum, P B Maples. Assessment of intravenous pbi-shRNA PDX1 nanoparticle (OFHIRNA-PDX1) in yucatan swine. Cancer Gene Therapy 2013; 20(12): 683 doi: 10.1038/cgt.2013.68
|
| 18 |
Cristiana Pistol Tanase, Monica Neagu, Radu Albulescu, Mihail Eugen Hinescu. . Advances in Clinical Chemistry 2010; 51: 145 doi: 10.1016/S0065-2423(10)51006-0
|
| 19 |
Shi‐He Liu, Sanjeet Patel, Marie‐Claude Gingras, John Nemunaitis, Guisheng Zhou, Changyi Chen, Min Li, William Fisher, Richard Gibbs, F. Charles Brunicardi. PDX‐1. Cancer 2011; 117(4): 723 doi: 10.1002/cncr.25629
|
| 20 |
Chihiro Gandou, Kenichi Harada, Yasunori Sato, Saya Igarashi, Motoko Sasaki, Hiroko Ikeda, Yasuni Nakanuma. Hilar cholangiocarcinoma and pancreatic ductal adenocarcinoma share similar histopathologies, immunophenotypes, and development-related molecules. Human Pathology 2013; 44(5): 811 doi: 10.1016/j.humpath.2012.08.004
|
| 21 |
JIE MA, JIA LI, HUA LI, XIGANG XIAO, LEI SHEN, LIN FANG. Downregulation of pancreatic-duodenal homeobox 1 expression in breast cancer patients: A mechanism of proliferation and apoptosis in cancer. Molecular Medicine Reports 2012; 6(5): 983 doi: 10.3892/mmr.2012.1067
|
| 22 |
Erica Dugnani, Valeria Sordi, Silvia Pellegrini, Raniero Chimienti, Ilaria Marzinotto, Valentina Pasquale, Daniela Liberati, Gianpaolo Balzano, Claudio Doglioni, Michele Reni, Alessandra Gandolfi, Massimo Falconi, Vito Lampasona, Lorenzo Piemonti. Gene expression analysis of embryonic pancreas development master regulators and terminal cell fate markers in resected pancreatic cancer: A correlation with clinical outcome. Pancreatology 2018; 18(8): 945 doi: 10.1016/j.pan.2018.09.006
|
| 23 |
Karl Quint, Sebastian Stintzing, Beate Alinger, Cornelia Hauser-Kronberger, Otto Dietze, Susanne Gahr, Eckhart G. Hahn, Matthias Ocker, Daniel Neureiter. The Expression Pattern of PDX-1, SHH, Patched and Gli-1 Is Associated with Pathological and Clinical Features in Human Pancreatic Cancer. Pancreatology 2009; 9(1-2): 116 doi: 10.1159/000178882
|
| 24 |
Philipp Manegold, Keane Lai, Yongfeng Wu, Jia-Ling Teo, Heinz-Josef Lenz, Yuri Genyk, Stephen Pandol, Kaijin Wu, David Lin, Yibu Chen, Cu Nguyen, Yi Zhao, Michael Kahn. Differentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic Cancer. Cancers 2018; 10(4): 95 doi: 10.3390/cancers10040095
|
| 25 |
Gregory Sergeant, Hugo Vankelecom, Lies Gremeaux, Baki Topal. Role of cancer stem cells in pancreatic ductal adenocarcinoma. Nature Reviews Clinical Oncology 2009; 6(10): 580 doi: 10.1038/nrclinonc.2009.127
|
| 26 |
Shi-He Liu, Guisheng Zhou, Juehua Yu, James Wu, John Nemunaitis, Neil Senzer, David Dawson, Min Li, William Fisher, F. Brunicardi. Notch1 Activation Up-Regulates Pancreatic and Duodenal Homeobox-1. Genes 2013; 4(3): 358 doi: 10.3390/genes4030358
|
| 27 |
Marco Marzioni, Ugo Germani, Laura Agostinelli, Giorgio Bedogni, Stefania Saccomanno, Francesco Marini, Stefano Bellentani, Carmelo Barbera, Samuele De Minicis, Chiara Rychlicki, Alfredo Santinelli, Maurizio Ferretti, Pier Vittorio Di Maira, Gianluca Svegliati Baroni, Antonio Benedetti, Giancarlo Caletti, Ivano Lorenzini, Pietro Fusaroli. PDX-1 mRNA expression in endoscopic ultrasound-guided fine needle cytoaspirate: Perspectives in the diagnosis of pancreatic cancer. Digestive and Liver Disease 2015; 47(2): 138 doi: 10.1016/j.dld.2014.10.010
|
| 28 |
Yanjiao Zhang, Xinyi Fang, Jiahua Wei, Runyu Miao, Haoran Wu, Kaile Ma, Jiaxing Tian. PDX-1: A Promising Therapeutic Target to Reverse Diabetes. Biomolecules 2022; 12(12): 1785 doi: 10.3390/biom12121785
|